"Estrogens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
Descriptor ID |
D004967
|
MeSH Number(s) |
D27.505.696.399.472.277
|
Concept/Terms |
Estrogens- Estrogens
- Estrogenic Compounds
- Compounds, Estrogenic
- Estrogenic Agents
- Agents, Estrogenic
- Estrogen
- Estrogen Receptor Agonists
- Agonists, Estrogen Receptor
- Receptor Agonists, Estrogen
Estrogen Effect- Estrogen Effect
- Estrogenic Effect
- Estrogenic Effects
- Effects, Estrogenic
- Estrogen Effects
- Effects, Estrogen
|
Below are MeSH descriptors whose meaning is more general than "Estrogens".
Below are MeSH descriptors whose meaning is more specific than "Estrogens".
This graph shows the total number of publications written about "Estrogens" by people in this website by year, and whether "Estrogens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 1 | 2 |
2009 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2019 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estrogens" by people in Profiles.
-
Bioavailability and impacts of estrogenic compounds from suspended sediment on rainbow trout (Oncorhynchus mykiss). Aquat Toxicol. 2021 Feb; 231:105719.
-
Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome. Exp Clin Endocrinol Diabetes. 2020 Nov; 128(11):723-730.
-
Possible role of PGRMC1 in breast cancer development. Climacteric. 2013 Oct; 16(5):509-13.
-
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. Menopause. 2013 May; 20(5):504-10.
-
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecol Endocrinol. 2013 Feb; 29(2):160-3.
-
Investigation of variants of the aromatase gene (CYP19A1) in female pattern hair loss. Br J Dermatol. 2011 Sep; 165(3):703-5.
-
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res. 2009; 11(4):R59.
-
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res. 2008; 10(5):R85.
-
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients. Breast Cancer Res. 2008; 10(5):R76.